Health Category

Vaccination Guides & Resources

Objective medical guide and reviews on Vaccination.

Articles in Vaccination (6)

View all articles
Adult Immunization Schedule: Clinical Evidence, Schedules & Vaccine LiteracyVaccination
2026-08-08 4210

Adult Immunization Schedule: Clinical Evidence, Schedules & Vaccine Literacy

Immunization is not just for children. As adults age, antibody titers from childhood vaccines wane, and immunosenescence weakens adaptive immune surveillance. Explore the official CDC Advisory Committee on Immunization Practices (ACIP) adult schedule—including Tdap boosters, Shingrix shingles protection, conjugate pneumococcal vaccines, and recombinant HPV guidelines.

Shingles Vaccine (Shingrix): Two-Dose Schedule, Side Effects, and Eligibility for Adults 50+Vaccination
2026-08-08 4610

Shingles Vaccine (Shingrix): Two-Dose Schedule, Side Effects, and Eligibility for Adults 50+

Herpes Zoster (Shingles) is an excruciating, dermatomal viral reactivation disease that affects 1 in 3 adults during their lifetime. Explore the molecular immunology of the recombinant adjuvanted zoster vaccine (Shingrix), the CDC 2-dose intramuscular schedule for adults aged ≥50, clinical prevention of postherpetic neuralgia (PHN), and anticipated reactogenicity.

HPV Vaccine: Cancer Prevention, Recommended Age Windows, and Safety GuidelinesVaccination
2026-08-08 4720

HPV Vaccine: Cancer Prevention, Recommended Age Windows, and Safety Guidelines

Human Papillomavirus (HPV) is the most common sexually transmitted infection worldwide and the direct causative agent of >90% of cervical, anal, oropharyngeal, penile, and vulvar/vaginal cancers. Explore the molecular viral oncoproteins (E6/E7), the 9-valent recombinant vaccine (Gardasil-9), CDC age recommendations (routine ages 9–12 through age 26, and 27–45 via shared clinical decision), and long-term real-world safety.

Pneumococcal Vaccines for Older Adults: Understanding PCV15, PCV20, and PPSV23Vaccination
2026-08-08 4520

Pneumococcal Vaccines for Older Adults: Understanding PCV15, PCV20, and PPSV23

*Streptococcus pneumoniae* (pneumococcus) is a virulent Gram-positive pathogen responsible for severe community-acquired pneumonia, bacteremia, and meningitis in older adults and immunocompromised individuals. Explore the updated CDC ACIP adult pneumococcal guidelines, the difference between conjugate (PCV15, PCV20) and polysaccharide (PPSV23) vaccines, T-cell dependent immune memory, and clinical decision algorithms.

Meningococcal Vaccines (MenACWY and MenB): Schedule, College Risks, and Disease PreventionVaccination
2026-09-11 1810

Meningococcal Vaccines (MenACWY and MenB): Schedule, College Risks, and Disease Prevention

Meningococcal disease caused by *Neisseria meningitidis* is a devastating bacterial infection that can cause fatal meningitis or purpura fulminans septicemia within 24 hours. Understand the two complementary vaccines (Quadrivalent MenACWY and Serogroup MenB), standard adolescent CDC vaccination timelines (ages 11–12 and 16 booster), college dormitory risks, and clinical symptom recognition.

Tdap Booster Vaccine: Tetanus, Diphtheria, Pertussis Timing, Pregnancy, and Wound CareVaccination
2026-09-12 1960

Tdap Booster Vaccine: Tetanus, Diphtheria, Pertussis Timing, Pregnancy, and Wound Care

The Tdap vaccine protects against three potentially fatal bacterial exotoxin diseases: Tetanus (*Clostridium tetani*), Diphtheria (*Corynebacterium diphtheriae*), and Pertussis / Whooping Cough (*Bordetella pertussis*). Review standard 10-year adult booster intervals, essential maternal immunization during weeks 27–36 of each pregnancy, cocooning strategies for newborns, and emergency dirty wound prophylaxis.